Voyager Therapeutics Inc (VYGR)
6.685
-0.14
(-2.12%)
USD |
NASDAQ |
Nov 13, 16:00
6.685
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Revenue (Annual): 250.01M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 250.01M |
| December 31, 2022 | 40.91M |
| December 31, 2021 | 37.42M |
| December 31, 2020 | 171.13M |
| December 31, 2019 | 104.39M |
| Date | Value |
|---|---|
| December 31, 2018 | 7.619M |
| December 31, 2017 | 10.14M |
| December 31, 2016 | 14.22M |
| December 31, 2015 | 17.33M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
37.42M
Minimum
2021
250.01M
Maximum
2023
120.77M
Average
104.39M
Median
2019
Revenue (Annual) Benchmarks
| Rhythm Pharmaceuticals Inc | 77.43M |
| NovaBay Pharmaceuticals Inc | 14.73M |
| Palatin Technologies Inc | 4.490M |
| iBio Inc | 0.225M |
| Theriva Biologics Inc | -- |